Author:
Kyte Derek,Reeve Bryce B.,Efficace Fabio,Haywood Kirstie,Mercieca-Bebber Rebecca,King Madeleine T.,Norquist Josephine M.,Lenderking William R.,Snyder Claire,Ring Lena,Velikova Galina,Calvert Melanie
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference19 articles.
1. EMA. (2014). Reflection Paper on the use of patient reported outcome (PRO) measures in oncology studies [Draft]. European Medicines Agency, Oncology Working Party; Doc. Ref. EMA/CHMP/292464/2014.
2. EMA. (2005). Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. European Medicines Agency, Committee for medicinal products for human use (CHMP); Doc. Ref. EMEA/CHMP/EWP/139391/2004.
3. ISOQOL. (2015). International Society for Quality of Life Research. http://www.isoqol.org/research/isoqol-publications . Accessed July 2015.
4. Kyte, D., Ives, J., Draper, H., Keeley, T., & Calvert, M. (2013). Inconsistencies in quality of life data collection in clinical trials: A potential source of bias? Interviews with research nurses and trialists. PLoS One, 8(10), e76625.
5. Kyte, D. G., Draper, H., Ives, J., Liles, C., Gheorghe, A., & Calvert, M. (2013). Patient reported outcomes (PROs) in clinical trials: is ‘in-trial’ guidance lacking? A systematic review. PLoS One, 8(4), e60684.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献